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Abstract: Public health teams need to understand how the public responds to vaccination messages 
in a pandemic or epidemic to inform successful campaigns encouraging the uptake of new vaccines 
as they become available. A rapid systematic review was performed by searching PsycINFO, MED-
LINE, healthevidence.org, OSF Preprints and PsyArXiv Preprints in May 2020 for studies including 
at least one health message promoting vaccine uptake of airborne-, droplet- and fomite-spread vi-
ruses. Included studies were assessed for quality using the Mixed Methods Appraisal Tool (MMAT) 
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or the Assessment of Multiple Systematic Reviews (AMSTAR), and for patient and public involve-
ment (PPI) in the research. Thirty-five articles were included. Most reported messages for seasonal 
influenza (n = 11; 31%) or H1N1 (n = 11; 31%). Evidence from moderate to high quality studies for 
improving vaccine uptake included providing information about virus risks and vaccination safety, 
as well as addressing vaccine misunderstandings, offering vaccination reminders, including vac-
cination clinic details, and delivering mixed media campaigns across hospitals or communities. Be-
havioural influences (beliefs and intentions) were improved when: shorter, risk-reducing or relative 
risk framing messages were used; the benefits of vaccination to society were emphasised; and beliefs 
about capability and concerns among target populations (e.g., vaccine safety) were addressed. Clear, 
credible, messages in a language target groups can understand were associated with higher accept-
ability. Two studies (6%) described PPI in the research process. Future campaigns should consider 
the beliefs and information needs of target populations in their design, including ensuring that vac-
cine eligibility and availability is clear, and messages are accessible. More high quality research is 
needed to demonstrate the effects of messaging interventions on actual vaccine uptake. 




Scientists have made significant, rapid breakthroughs to protect communities against 
the novel SARS-CoV-2 virus and several vaccines have been approved globally [1–4]. Vac-
cination reduces the burden of infectious diseases, which can be eliminated locally if 
enough of the population takes up the vaccine [5], with 80% of healthy people and 90% of 
high-risk individuals reportedly required to establish herd immunity against influenza 
[6]. However, there is concern that not enough people will take up vaccines against SARS-
CoV-2 once they become available. Global surveys of adults found willingness to have a 
vaccination (i.e., those who agreed or strongly agreed that they would get a SARS-CoV-2 
vaccine if it were available) was 71.5% in June [7], 74.5% in August, 72.4% in October, and 
65.8% in December 2020 [8]. Among adults at increased risk of developing severe COVID-
19 (including older people, people with existing long-term conditions, and pregnant 
women), 80% were willing to accept a new vaccine when surveyed between April and 
June 2020 [9]. Even if willingness translates perfectly into vaccine uptake, it is still likely 
that vaccine hesitancy will impact the vaccination effort against SARS-CoV-2 among at-
risk groups. There is some evidence that this hesitancy is increasing in healthy adults in 
the majority of countries, with vaccine hesitancy above 50% in France and Russia [8]. 
Research has shown a variety of psychological factors are associated with vaccine 
hesitancy. Beliefs can be held on risk of infection, severity of the public health issue, se-
verity of personal consequences due to illness, the consequences of vaccination [10,11], 
and the effectiveness of vaccines [11,12]. Reasons for hesitancy towards having a vaccine 
against SARS-CoV-2 include a lack of understanding about vaccine eligibility, worry 
about side effects, beliefs that the vaccination is not effective, perceptions of not being at 
sufficient risk from SARS-CoV-2, being against vaccines in principle, and not having the 
time [8,10]. 
Early findings also demonstrate variation in hesitancy among sub-groups within the 
population. Respondents who were younger, from Black, Asian, and minority ethnic 
(BAME) backgrounds, or had lower education levels, were significantly less willing to be 
vaccinated [9,13]. Smokers and people who had previously contracted SARS-CoV-2 have 
also been found to be less willing to be vaccinated [9]. This suggests that people who are 
hesitant are likely to hold different beliefs and values, and any future efforts to encourage 
vaccination should account for this variation. 
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Furthermore, intentions to receive a vaccination, and vaccination uptake, have been 
found to vary over the different phases of a pandemic. During the H1N1 pandemic, stud-
ies highlighted a declining trend, with intention decreasing post-pandemic when a vac-
cine became available [11]. A seasonal influenza vaccine is offered each year in the UK to 
individuals at risk of poor influenza outcomes, with uptake among adults over 65 between 
71% and 75% [14], but uptake among other clinical risk groups under 65 is lower and 
trending downwards from 48% in 2018–2019 to 45% in 2019–2020 [15]. This suggests that 
there may be changes in the intentions and actions of individuals over time that may be 
influenced by reduced risk perception as a pandemic or epidemic becomes more con-
trolled and treatments are improved. This may well have been the case for H1N1 where 
the vaccine became available post-pandemic once the virus had run its course [11]. 
Determining the success of previous health campaigns relating to pandemics and ep-
idemics can inform future communication strategies for promoting vaccine uptake. The 
best evidence for a successful vaccination campaign is if the messaging affects uptake. 
Changes in uptake are mediated by psychological processes, and public health campaigns 
should formally consider variables such as intentions, beliefs, and gaps in understanding 
about vaccines and how they work. Campaigns should also consider the public’s chang-
ing information needs during the various phases of a pandemic or epidemic as well as the 
needs of particular groups. One way to improve public health messages is to include tar-
get populations in their design and dissemination. A recent comprehensive review of pub-
lic health messaging recommended engaging communities in the development of public 
health messages [16]. By involving key stakeholders in the design of public health mes-
saging, materials will be co-created with the understanding of those we wish to engage in 
target behaviours. The aim of the present review therefore was to identify and synthesise 
evidence relating to effective messaging for encouraging vaccination in order to prevent 
virus transmission during pandemics or epidemics. The degree to which the public have 
been involved in public health messages included in this review will also be determined. 
2. Materials & Methods 
2.1. Protocol 
The protocol for a broader systematic review of public health messaging was 
amended on 6th August 2020 to include the present review of vaccine messaging: PROS-
PERO Ref. CRD42020188704. 
2.2. Search Strategy and Selection Criteria 
Searches for published and unpublished studies were performed in May 2020 using 
Ovid PsycINFO, Ovid MEDLINE and healthevidence.org, and OSF Preprints and 
PsyArXiv Preprints, respectively. All research designs were considered for inclusion. The 
search strategy was developed and conducted for a broader systematic review of public 
responses to public health messaging by the same authors and is reported elsewhere [16]. 
Retrieved references were exported into Rayyan [17]. We conducted a keyword search 
including “vaccine”, “vaccines” and “vaccination” of all studies identified as eligible for 
full text screening [16]. All studies including these terms in the title or abstract were 
screened at full text by two of nine of the authors (S.L.-W., D.G., M.Y.T., J.W., S.S., E.J., 
N.G., D.S. & A.P.K.) and any disagreements were reviewed by a third author until con-
sensus was reached. Reference lists of eligible studies were hand searched only if the ar-
ticle mentioned potentially relevant additional studies, due to the rapid nature of this re-
view. Non-English language articles and dissertations were also excluded due to time re-
strictions. 
Studies were included if they tested the impact of at least one type of public health 
message (e.g., television broadcasts, websites, text alerts) on vaccination-related behav-
iours or psychological variables with adults, and included viruses spread from human-
to-human with primary transmission being airborne, droplet and fomite (touch) contact. 
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Studies which focused on sexually transmitted infections, for example HIV, were ex-
cluded as they were considered to be significantly different from those of interest for this 
review. Studies already contained within eligible systematic reviews were not included 
as individual primary studies to avoid duplication of data and over-emphasising evidence 
from a single study. 
2.3. Data Extraction 
A data extraction form was developed by the authors based on the SPICE criteria 
(Setting, Perspective, Phenomena of Interest, Comparison, Evaluation, Time Scope) [18]. 
2.4. Risk of Bias Assessment 
Quality assessment checks were performed independently by six of the review au-
thors (S.L.-W., E.J., L.B.D., D.S., D.G. & M.Y.T.) for all eligible articles included in the re-
view. Double quality assessment was not performed due to time restrictions. The Mixed 
Methods Appraisal Tool (MMAT [19]) was used to review the quality of primary studies 
of any design. The Assessment of Multiple Systematic Reviews (AMSTAR [20]) was used 
to review the quality of reviews and systematic reviews. Therefore, each included article 
received one quality score. Low quality was categorised as 0–1 on MMAT or 0–3 on AM-
STAR; moderate quality was categorised as 2–3 on MMAT and 4–6 on AMSTAR; and high 
quality was categorised as 4–5 on MMAT and 7–10 on AMSTAR. 
2.5. Patient and Public Involvement (PPI) 
We performed an assessment of the involvement of patients or the public in the final 
included studies. Two of the authors (T.E. & L.L.) developed a PPI Checklist, which was 
based on a study investigating the reporting of PPI within research articles [21]. The check-
list was used to rate the type and extent of PPI that has been reported in studies, for ex-
ample being involved in the study steering group by responding “No”, “Yes”, or “Un-
clear” for each type of PPI. Two additional authors (D.G. & S.L.-W.) reviewed the draft 
version of the PPI Checklist and all four authors agreed on the final version (Supplemen-
tary Table S1). 
3. Results 
3.1. Study Selection 
The full texts of 110 articles identified from the broader review of public health mes-
saging [16] were screened for eligibility. A total of 35 studies were included in the review 
(Figure 1), the majority being primary studies (n = 30), with a small number of systematic 
reviews (n = 3) and two editorial reviews (n = 2). 




Figure 1. PRISMA Flow Chart. 
3.2. Study Characteristics 
Characteristics of the articles included in the review and the types of intervention 
evaluated in included studies are presented in Supplementary Table S2. Messages in-
cluded emails, letters, leaflets, text messages, websites, television broadcasts, newspaper 
articles, and mass media campaigns and encouraged vaccination for: seasonal influenza 
(n = 11) [22–32], H1N1 influenza (n = 11) [33–43], measles, mumps and rubella (n = 1) [44] 
and pneumococcal infection (n = 1) [45]. Two studies reported potential future vaccination 
for avian influenza (n = 1) [46] and Ebola (n = 1) [47]. A further nine studies reported mes-
sages for vaccines for influenza that were not specified (n = 4) [48–51] and hypothetical 
influenza scenarios (n = 5) [52–56]. Studies were conducted in the United States (US) [22–
24,27,28,32,37–40,44–46,48,51,53,54], Singapore [25], UK [26,29,43,52,55], Italy [30,42], 
Australia [31,36], Hong Kong [32], China [33], Taiwan [34,41], Canada [35,56], Germany 
[49], Thailand [50], and Switzerland [47]. Study populations included college or university 
students and/or staff (n = 10) [22,27,28,32,34,39,43,47,49,54], general public (n = 9) 
[25,33,42,45,46,52,53,55,56] adults over 50 years (n = 4) [24,30,40,48], pregnant women (n = 
3) [23,38,51], hospital attendees (including non-clinical staff) (n = 2) [36,41], adults with 
long-term conditions or unspecified “high risk” (n = 3) [26,31,50], healthcare workers (n = 
1) [36] and Aboriginal First Nations and Metis adults (n = 1) [35]. A population of interest 
was not specified for three reviews [29,37,44]. 
3.3. Risk of Bias 
Half of the studies (n = 18; 50%) scored highly on their respective quality assessment tools 
[23,26,29–31,35–38,40,43,48,52–56] (Table 1). Three studies and two editorial reviews were 
found to be of low quality [32,41,44,49,51] while the remaining were of moderate quality. 
3.4. Results of Individual Studies 
A summary of the main results is reported in Table 1.
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3.5. Synthesis of Results 
3.5.1. Evidence of Impact of Messaging on Behaviour 
A total of 12 out of 35 included articles reported vaccination uptake among their popula-
tions of interest. These were for the seasonal influenza [22,23,26,29,31], H1N1 [33,36,37,42], 
unspecified influenza [50,51], and pneumococcal vaccines [45]. Eight studies described suc-
cessful vaccine promotion campaigns for increasing uptake. These included community- 
[29,45] or hospital-wide [29] mixed media messages, text message prompts sent from local 
physician clinics to adults from high risk groups [23,31,51], text prompts with information 
about virus prevention and addressing misunderstandings about vaccination [33], the inclu-
sion of a map with vaccination clinic locations in an email [22], and ensuring messages were 
credible, clear and provided honest information about pandemic influenza vaccination [37]. 
Studies showing no impact of messages on vaccination included leaflets providing infor-
mation about influenza and the benefits of vaccination [50], a text message reminder prompt 
from a local practice [26] and an educational TV campaign encouraging a range of preventa-
tive behaviours including vaccination [42]. One cross-sectional study did not measure vaccine 
uptake robustly enough to make conclusions about whether mixed media messages had an 
impact on this behavioural outcome [36]. 
3.5.2. Evidence of Impact of Messaging on Behavioural Influences 
Intentions or Willingness to Take up Vaccination 
A total of 18 out of the final 35 studies reported either intentions, or willingness, of 
individuals towards taking up vaccination for seasonal influenza [25,27–30,32], H1N1 
[34,36,38,40], unspecified influenza [50], Ebola [47], MMR [44], avian influenza [46] and in 
a hypothetical influenza scenario [52–56]. Eleven studies described successful vaccine pro-
motion messages for improving either intentions or willingness, including framing losses 
when the message was collectivist [32,40], and when text was used [28,34], framing gains 
by emphasising benefits to society [44,46], using formal (rather than colloquial) language 
[25] and shorter messages [52], leaflets including information about virus susceptibility 
and severity and benefits of vaccination [50], presenting risks in a socially and personally 
relevant way [56], media multitasking while viewing health websites [54], and presenting 
messages on white backgrounds with red text [34]. Interventions showing no impact of 
messages on intentions or willingness included using personal stories in messages [30] 
and messages including basic risk information alone [27]. Emphasising uncertainty in 
messages [53] had a negative impact on willingness to be vaccinated in a hypothetical 
influenza scenario. 
Beliefs and Attitudes about Vaccines and Vaccination 
A total of 15 of the final 35 studies reported the attitudes (i.e., the positive and nega-
tive evaluations of the vaccines) and beliefs (e.g., beliefs about capability to take up vac-
cines, beliefs about the consequences of having a vaccine) of the general public or specific 
population groups towards vaccination for seasonal influenza [27,28,30,32,36], Ebola vi-
rus [47], H1N1 [40,43], and unspecified [48–50] or hypothetical [52,53,55,56] influenza vi-
ruses, and the impact of messages on these beliefs. Messages improving attitudes towards 
vaccination included loss framed messages with collectivist appeals [32] when presented 
as text (rather than images) [28], and gain framed messages including images [28]. Suc-
cessful messages for improving perceived effectiveness or benefits of vaccines empha-
sised reduction in risks [52] and used relative risk framing [56]. Leaflets that were person-
ally relevant and emphasised susceptibility and severity of viruses and the benefits of 
vaccination increased beliefs about capability to get vaccinated [50], as did narrative mes-
sages including personal accounts of people who took up a vaccine [30]. Campaigns which 
influenced negative beliefs about vaccination included messages not providing honest 
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safety information about vaccines [55], messages using “fear appeals” including images 
of children with MMR [44] and over-emphasising the dangers of viruses [47], and empha-
sising uncertainty [53]. Three studies also reported that providing official information 
sources [49], emphasising the safety and effectiveness of vaccines [48], and providing 
basic information about the risk of vaccines [27] were also found to have a negative impact 
on beliefs about vaccine effectiveness. 
3.5.3. Evidence on Information Needs 
A total of 12 of the final 35 studies reported acceptability to the general public or 
specific population groups of messages, and/or on levels of knowledge or understanding 
of the information shared in messages. These studies were conducted in the contexts of 
seasonal influenza [24,28,30,32], H1N1 [34,35,38,39], hypothetical influenza [52,55], and 
unspecified influenza [48,50]. Messages found acceptable by target audiences include fac-
tual, risk-reducing messages [55], narrative messages [30] gain-framed messages [32], 
loss-framed messages [34], and risk-reducing messages [52]. Less acceptable messages in-
cluded health-enhancing messages [28], and those eliciting anticipated regret [28]. Two 
moderate quality studies found that vaccination campaigns improved knowledge about 
side effects [24,50]. When only facts were used, this did not improve information recall 
over the use of facts alongside myths, or when facts, myths and refutations were used [24]. 
Both leaflets used in a study by Payaprom et al. [50] also improved knowledge of side 
effects, and were similar in their inclusion of details about influenza and the benefits of 
vaccination. 
Information needs of target populations highlighted by studies included gaps in un-
derstanding of how long it takes to build immunity following vaccination [48], whether 
vaccines for one virus can offer protection against another [36], and unfamiliarity with 
vaccine-related terminology [38]. When health information was presented through narra-
tives whereby the target population was the centre of the story, these messages were better 
understood than didactic messages that aimed to instruct [30]. 
3.6. Patient and Public Involvement (PPI) 
Only two out of 35 articles described the involvement of patients or the public in the 
research process. One study included the public in the intervention design and in the 
steering group [45]. A further study involved the public in identifying priorities and in 
the design [35]. No studies involved patient or public involvement groups in the analysis 
or interpretation of their findings. 
4. Discussion 
4.1. Summary of Evidence 
The aim of this rapid systematic review was to identify and synthesise evidence re-
lating to effective messaging on vaccination-related behavioural or psychological varia-
bles in a pandemic or epidemic. This review identified a variety of messages reported by 
35 articles used to encourage vaccine uptake. There is evidence among moderate to high 
quality studies of suitable message content and targeting for improving vaccine uptake. 
There was also evidence from moderate to high quality studies of suitable message for-
matting, framing and content to support vaccination beliefs and intentions, message com-
prehension and acceptability. These findings are supported by previous evidence related 
to other public health campaigns identified in a broader systematic review of messaging 
not specific to vaccine uptake [16] (Table 2). 
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Table 2. Summary of moderate to high quality evidence of methods to support vaccination uptake, beliefs and intentions 
with supporting evidence from a broader review of public health messaging [16]. 
Methods to Support Acceptable Messages Evidence Quality of Evidence Supporting Evidence 
Uptake 
Community-wide mixed media campaigns found to be effective 





High Use different media for delivery and 
match delivery to the population’s 
needs and perceptions [16] Hospital-wide mixed media campaigns including educational and 






Text messages including information about health risks, vaccine 
safety and recommending vaccination were effective for 
increasing vaccine uptake among pregnant women.  
[23] High 
Increase the public’s awareness of the 
risks of the virus to their own health 
and the health of others [16] 
Community-wide text message prompts with information about 
virus prevention and addressing misunderstandings about 
vaccination increased vaccination uptake among the general 
population 
[33] Moderate 
Identify inconsistencies in messages 
from uncontrolled sources, especially 
when addressing key preventative 
behaviours [16]  
Including a map with the locations of influenza vaccination clinics 
in email invitations for vaccinations increased vaccination uptake. [22] Moderate 
Frame the message to emphasise 
positive beliefs about one’s own health 
and that preventative behaviour is 
within one’s control [16] 
Psychological influences over uptake 
Shortened messages from official sources that were personally 
relevant, included information about susceptibility, and were risk-
reducing were more effective than longer messages for improving 
willingness to be vaccinated. 
[52] High 
Deliver consistent, clear, core messages 
about risk and preventative behaviour 
across sources within the same time 
points [16] 
Fear of side effects, concerns about risks to unborn baby, and 
unfamiliarity with vaccine terminology in messages were found 
among pregnant women, impacting on vaccination intentions.  
[38] High 
Tailor key messages to be applicable to 
an individual’s situation [16] 
Vaccine safety concerns may arise from messages about the speed 
new vaccines have been tested during pandemics and have 
impacted on willingness to be vaccinated.  
[43] High 
Be transparent: admit errors and 
unknowns whenever appropriate [16] 
Messages focused on benefits to society were found to be more 
effective than messages emphasising benefits to the self, to 
increase vaccination intentions. 
[46] Moderate 
Consider framing messages around 
social responsibility and norms [16] 
A leaflet including influenza susceptibility, severity, vaccination 
benefits and efficacy, and behaviour change techniques including 
providing information about the behaviour-health link and 
personal accounts of people who received vaccination increased 
vaccination intentions 
[50] Moderate 
Increase the public’s awareness of the 
risks of the virus to their own health 
and the health of others [16] 
Factual, risk-reducing messages were perceived as more credible 
and resulted in beliefs vaccination is more beneficial than 




Increase factual knowledge of all 
aspects of a virus (e.g., symptoms) and 
benefits of preventative behaviour 
using an appropriate message frame 
[16] 
Providing baseline information about risk alongside relative risk 
framing to communicate risk can result in stronger beliefs about 





Accurately describe the health threat, 
severity of the threat, the risk to self 
and others, coupled with information 
about how to reduce the risk [16] 
Narrative messages targeting confidence in vaccines, including 
stories of adults over 65 affected by seasonal influenza who got 
vaccinated, improved beliefs about capability to take up a vaccine. 
[30] High 
Tailor key messages to be applicable to 
an individual’s situation [16] 
Pairing images of young adults while emphasising gains 
associated with vaccination, or framing losses with text (i.e., 
[28] Moderate 
Increase factual knowledge of all 
aspects of a virus (e.g., symptoms) and 
benefits of preventative behaviour 
Vaccines 2021, 9, 72 21 of 26 
 
 
avoiding the use of negative imagery) increased confidence in 
vaccination effectiveness among young adults 
using an appropriate message frame 
[16] 
Web pages describing general information about Ebola and efforts 
involved in developing a vaccine and providing strong statements 
about self-efficacy and response efficacy were linked to more 
favourable attitudes towards vaccination.  
[47] Moderate 
Accurately describe the health threat, 
severity of the threat, the risk to self 
and others, coupled with information 
about how to reduce the risk [16] 
Acceptability of messages & information needs 
A lack of clarity in messages using vaccine-related terminology 
and scientific information (e.g., the time it takes to build 





Engage with key stakeholders and 
communities [16] 
High risk groups may perceive priority to be vaccinated using 
new vaccines as a form of discrimination, impacting negatively on 
attitudes towards the message. 
[35] High 
Use messaging that empowers 
communities to take control of their 
own health [16] 
Factual, risk-reducing messages may be perceived as more 
credible than health-enhancing messages 
[55] High 
Increase factual knowledge of all 
aspects of a virus (e.g., symptoms) and 
benefits of preventative behaviour 
using an appropriate message frame 
[16] 
Messages from official sources challenging myths may be more 
effective than providing facts alone for improving knowledge 
about vaccines 
[24] Moderate 
Identify inconsistencies in messages 
from uncontrolled sources, especially 
when addressing key preventative 
behaviours [16]  
4.2. Improvements to Messaging 
Our findings indicate there is room for improvement in future vaccination campaigns 
during pandemics and epidemics, not only from the evidence for successful campaigns, 
but also where our review has highlighted inconsistencies. Our review found how mes-
sages are framed, in terms of the losses of non-vaccination and gains associated with vac-
cination, can have an impact on intentions to vaccinate. However, there were mixed find-
ings on the way that potential gains and losses should be framed to improve vaccination 
beliefs and intentions. The evidence was generally of poor quality [28,32,40] and as such 
we identified no good quality evidence that loss-framed messages were more effective 
than gain-framed messages for increasing intentions. Furthermore, whilst one moderate 
quality study reported formal rather than colloquial language improved intentions [25], 
this evidence is limited and it may be useful to consider language with caution. Studies 
measuring message comprehension have identified specific information needs of target 
populations, including the need to consider literacy and unfamiliarity with scientific ter-
minology [38,53]. It is important that public health teams ensure messages are clear, use 
an appropriate message frame, and are delivered in language target populations can un-
derstand. This can be achieved by co-designing messages alongside the communities 
teams are targeting in messages. 
Risk information, and information about vaccine efficacy and benefits, can influence 
intentions or willingness to vaccinate but may need to be presented in a particular way. 
Relative risk information, for example expressing a risk reduction from 4% to 2% as ‘‘re-
duced by 50%”, was more effective at increasing willingness to vaccinate against a hypo-
thetical influenza than absolute risk information, for example expressing the same risk as 
“2% lower” [56]. The addition of risk information improved willingness to vaccinate when 
it was presented in a socially and personally relevant way in another study in the same 
high quality systematic review [56,61]. However, one moderate quality study found that 
the inclusion of risk information decreased intentions for season influenza vaccination 
uptake [27]. Risks of inaction, when presented as images or “dramatic” narratives in mes-
sages, can have a negative impact on beliefs about vaccines, as found by one low quality 
review of messages encouraging MMR vaccination where parents were more likely to be 
concerned about vaccine side effects [44]. 
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Evidence was also mixed from trials of text messages encouraging vaccine uptake, 
where uptake reportedly improved in four studies (ranging in quality) [23,31,33,51], but 
no effects were demonstrated in a fifth, high quality, study [26]. Notably, text messages 
were found in one review to be especially effective in certain populations, who may not 
represent more disadvantaged groups or people at high risk of severe disease [23]. Text 
messages were found especially effective in white people, aged 25–49, college educated, 
married, working, living at or above poverty level and having high risk conditions [23]. 
This suggests that public health teams should review the delivery preferences of target 
audiences and ensure intervention delivery methods (e.g., text message) are both accessi-
ble and acceptable for target groups. 
Messages that had negative impacts on the beliefs and intentions of target popula-
tions include health-enhancing messages, which were considered lacking in honesty 
about the potential harms of vaccination in two high quality studies [52,55]. This is in line 
with research demonstrating that trust reduces if information in public health messages 
is perceived to have been exaggerated [16]. Two high quality studies found factual, risk-
reducing messages were more effective than health-enhancing messages in encouraging 
beliefs that vaccination was more beneficial [52], and on perceptions that the message was 
more convincing and credible, than health-enhancing messages [55]. This highlights the 
importance of offering credible, honest, clear information in messages encouraging vac-
cination during health crises. Credibility and believability can increase the acceptability 
of messages. Public health authorities should therefore consider using a credible source 
in messaging, as supported by recent British Psychological Society (BPS) guidance for 
public health messaging during pandemics and epidemics [62]. 
This review also identified concern among populations about the risks of vaccines 
prompted by messages, which impacted on beliefs about vaccine effectiveness, including 
concerns about the consequences of vaccination (e.g., side effects), vaccine safety, and the 
speed vaccines have been developed to manage global pandemics. Similar concerns have 
been expressed by the public during the expedited development of vaccines for SARS-
CoV-2. Communication about rapid development risks can damage public confidence in 
the vaccines [63]. This suggests that encouraging vaccination through messages may in-
volve taking a more balanced approach in order to provide appropriate information to 
resolve the concerns of target populations. A recent systematic review of studies from the 
H1N1 pandemic found reporting the threat of a virus honestly, presenting both known 
and unknown factors, can improve the population’s perceptions and trust during times 
of public health crisis [37]. This is consistent with research specific to SARS-CoV-2 which 
found individuals reporting higher levels of trust in information from government 
sources were more likely to accept a new vaccine for SARS-CoV-2 [10]. Building trust 
within communities and ensuring messages come from trusted authorities have been 
identified as key strategies for any effort to support vaccination uptake in a recent report 
on behavioural considerations for acceptance and uptake of SARS-CoV-2 vaccines from 
the World Health Organization (WHO) [64]. 
The potential for public health messages to cause confusion among the public is an 
important finding and indicates that messages need to be well designed and timed. For 
example, confusion about whether or not the seasonal influenza vaccine was protective 
against H1N1 was perhaps unsurprising given government campaigns relating to the 
H1N1 pandemic also encouraged the public to be immunised against seasonal influenza 
[36]. Messages should therefore consider the impact of encouraging vaccination for mul-
tiple viruses, which may have differing eligibility criteria. Indeed, a lack of understanding 
about eligibility for vaccines in general was found in a recent survey [9]. These issues 
should be clarified in public messages, including clearly communicating the population(s) 
eligible for vaccines. For example, this review included the impact of messages encourag-
ing influenza vaccine uptake among pregnant women, with hesitancy identified during 
the H1N1 pandemic, and which was commonly related to beliefs about the vaccine being 
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new and the consequences of vaccination (e.g., fearing side effects) [38]. However, preg-
nant women are currently advised not to take up vaccines approved in the UK for SARS-
CoV-2 [65]. Messages should be tailored when new information becomes available as the 
pandemic or epidemic evolves [11,14,65]. 
This review identified evidence highlighting the importance of consulting groups at 
higher risk of contracting viruses when developing messages, so campaigns are sensitive 
to their needs and are not perceived to be discriminatory [35]. Arguably, the involvement 
of target populations should be central to future campaigns during pandemics or epidem-
ics, to ensure the concerns of specific populations are relevant and are addressed in an 
appropriate way [16]. Particularly in the context of communicating risks within public 
health messages, the WHO recommends including the community in planning, infor-
mation dissemination, and relationship building during public health crises to improve 
the public’s preparedness and responses [66]. Evidence suggests that the public pay more 
attention to messages if the community are involved in their development [16]. Only two 
studies included in this review mentioned including patients or the public in the research 
team. Future campaigns should therefore involve target audiences at the centre of their 
design and evaluation. 
A key outcome to evaluate the effectiveness of a vaccine message is to measure per-
formance of the actual behaviour (i.e., getting the vaccine). Despite this, only 12 out of the 
final 35 included articles reporting vaccination uptake among their populations of inter-
est. It is important to note that vaccination willingness or intentions, no matter how strong, 
may have little impact on behaviour. Willingness in particular lacks premeditation and is 
more weakly related to behaviour than intentions [67]. Only one study in this review ex-
plored whether intentions translated into vaccination uptake and found no influence [22]. 
This can be explained by the intention–behaviour gap which suggests intentions can be 
useful but are generally insufficient predictors of behaviour [68,69]. The intention–behav-
iour gap describes the failure to translate what we intend to do into action and has been 
studied in influenza vaccine hesitancy [70]. This suggests fewer people reporting inten-
tions to receive a vaccine would be likely to go on to be vaccinated and has implications 
for medical practice, particularly where vaccination involves adhering to two doses, such 
as in vaccines currently being approved for SARS-CoV-2. Intentions have also been found 
to change or waver over time, particularly during a pandemic or epidemic with no clear 
endpoint. Unstable intentions have been found to weaken the intention–behaviour rela-
tionship in the context of influenza vaccination uptake [71]. This study highlights how 
messaging can be used to stabilise intentions and strengthen the likelihood of following 
recommended behaviours. However, more high quality research evaluating the impact of 
vaccine messaging on behavioural outcomes is needed for firm conclusions to be made. 
This review has highlighted that more evaluations of public health campaigns en-
couraging vaccination during pandemics or epidemics are needed. Notably only three 
RCTs of interventions were identified [26,31,33], with this review consisting mainly of 
cross-sectional studies. All three RCTs compared vaccination text-messaging interven-
tions to a standard care group. The control conditions varied and in settings where texts 
were delivered by general practices it is possible that control participants were also ex-
posed to local public health campaigns. This highlights the need for more RCTs testing 
different types of messages over time, and capturing behavioural outcomes appropriately, 
as a pandemic or epidemic situation evolves. More research is also needed to establish 
whether the medium through which a message is delivered, e.g., text message, affects 
vaccine uptake. Evaluation plans should be embedded into the development of cam-
paigns encouraging vaccination to answer some of these remaining questions. Further-
more, this review identified only a small number of European studies, suggesting more 
studies are needed to establish the impact of efforts to encourage vaccination during pan-
demics and epidemics across Europe. 
4.3. Study Limitations 
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The studies included in this review were found to vary in quality. It is important to 
note the inclusion of experimental studies testing messages for hypothetical pandemic or 
epidemic scenarios (n = 5; 14%) where responses might not reflect those given by individ-
uals living through a global or local health crisis. Where the type of influenza virus in a 
further four studies was not specified, it is possible these scenarios too were hypothetical 
and the results from these studies may not be reflective of the reactions of the public to a 
genuine virus. Furthermore, almost a third of included studies recruited university stu-
dent samples (n = 10; 29%), the limitation of this being a disproportionate focus on the 
views and experiences of young adults, as compared to other groups (e.g., high risk 
groups) who are notably under-represented in studies testing vaccination messages iden-
tified in the present review. Meta-analysis was not possible in this review due to the het-
erogeneity of outcomes and outcome measures used by public health messaging studies. 
This highlights the need for a core outcome set (COS) in moving evaluation research for-
ward when measuring vaccine hesitancy and the impact of public health messages. 
This was a rapid systematic review, conducted under time constraints in order to be 
relevant and effective for the current pandemic. We used a small selection of vaccination-
related terms to search for relevant studies among a pool of studies identified using non-
vaccination terminology. However, the authors also added vaccination-related terms to 
the original search for studies related to public health messaging (reported elsewhere 
[16]), and checked references lists of key articles, which identified a similar number of 
additional articles, so while we might have omitted some relevant studies, this is unlikely 
to have been a significant number. Rapid review methods also included omitting non-
English language articles and dissertations, and it is possible relevant research was ex-
cluded. 
5. Conclusions 
The responses of the public to previous messages encouraging vaccines for epidemic 
or pandemic viruses could inform future campaigns for novel viruses such as SARS-CoV-
2. Messages could be improved by ensuring they address the information needs of target 
populations, use credible sources, are personally relevant, shorter, and are honest about 
what is known about vaccines without over-emphasising the health benefits of vaccina-
tion. Vaccine eligibility should be clear, which may involve tailoring messages as new 
information becomes available. Health authorities designing campaigns should review 
the delivery preferences of target populations to ensure messages are accessible and ac-
ceptable. Future public health campaigns should involve members of the public, and in 
particular people with lived experience of being at high risk of epidemic or pandemic 
viruses, in their design and evaluation. Overall, quality of the studies included in this 
review was moderate to high and the results of low-quality studies should be viewed with 
caution. There is a need for more rigorous evaluations of public health campaigns encour-
aging vaccine uptake, measuring behavioural outcomes. 
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